Spider venom could aid future drug discovery, say Galway researchers
University of Galway
's School of Natural Sciences could help with future drug discovery, its authors have said.
The research, published on Wednesday in the journal Biology Letters
,
analysed the venoms of more than 70 spider species.
Dr Kevin Healy, senior author and head of the macroecology lab at the School of Natural Sciences, said the study will help people to 'understand the evolution of spider venoms' and 'how some venoms may be of particular interest for future drug discovery'.
'Venoms, in general, are actually a really good place to go look for new drugs,' Dr Healy told The Irish Times.
READ MORE
'As a resource, they're incredible.'
He explained that the biomolecules in venoms have evolved to perform many functions, such as lowering blood pressure or disrupting the circulatory system. Scientists can 'see the exact molecules in there, and then see how effective they are'.
Venom could also potentially be used as an antimicrobial, an agent that kills microorganisms or stops their growth. In order to prevent spiders from getting an infection, there are often 'lots of antimicrobial molecules' in their venom glands, Dr Healy said.
Dr Michel Dugon, head of the Venom Systems Lab at the university's Ryan Institute, added: 'By understanding the fundamental drivers of venom evolution, we can better predict the types of biomolecules in spider venoms that have yet to be explored for drug discovery.'
The researchers discovered that diet is one of the most important drivers influencing the potency of spider venom. They found that spider venoms are 'prey-specific'.
'That means they are evolved to kill the thing they eat, they're not just evolved to kill things,' Dr Healy said.
He noted that a Brazilian wandering spider, for example, is dangerous to humans because we are mammals.
'They feed on some small mammals, and so their venoms have components in them that are really, really good at disrupting mammal physiology. So while they don't prey on us, they kill things similar enough to us to make them dangerous to us.'
By comparison, a giant house spider generally isn't dangerous to humans because it 'simply doesn't feed on anything related to us'.
Brazilian wandering spiders are not found in Ireland.
'You do have to go down to South America, or at least the American continent, to get in trouble with one of those,' Dr Healy said.
Another venomous spider not typically found in Ireland is the black widow, however one of its relatives – the false widow – poses a risk here.
'They're not the same ... but they are related and they do have pretty potent venom,' he said.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Irish Times
10 hours ago
- Irish Times
Former Mater Private CEO Fergus Clancy leaves €15.8 million estate
The former chief executive of the Mater Private Network of hospitals and clinics Fergus Clancy left an estate valued at €15.8 million, according to documents published by the Probate Office this week. Mr Clancy, of Lagore Road, Dunshaughlin, Co Meath , died aged in his late 50s at the Mater hospital in April 2024. The married father of two began his professional life in the post room of insurance company Church & General before gaining experience handling medical malpractice cases. He went on to establish his own consultancy, Circa Healthcare Consulting. He also proposed a centralised State insurance scheme for doctors that was then adopted by former minister for health Brian Cowen . Following the sale of his consultancy to Aon, Mr Clancy became chief executive of the Mater Private Network in 2005, later taking the role of executive chairman. The Fergus Clancy Bursary for Healthcare Leadership and Entrepreneurship is awarded by the Future Health Summit to fully fund a person's masters in healthcare leadership. The summit says the bursary is in honour of 'our friend and colleague Fergus Clancy who showed such ambition, passion, determination and leadership in Irish healthcare over his long and distinguished career'. Meanwhile, Mervyn Howard Heatley, of Ballyman Road, Bray , Co Wicklow , a farmer who was noted for his collection of steam traction engines and vintage tractors, left an estate valued at €12.17 million, when he died in October last year. Farmer and classic car enthusiast Mervyn Howard Heatley left more than €12 million in his will. Photograph: Mr Heatley, known as Howard, was a supporter of the Enniskerry Festival's Victorian Field Day, which was held on his farm on a number of occasions. His son, also called Mervyn, runs a vintage car dealership called Classic Prestige Cars, which is based at Ballyman Road, Bray. The will of Mary Keegan, Dogstown, Trim , Co Meath, outlined an estate valued at €5.2 million when she died in February 2024. Ms Keegan was the widow of quarrying company executive Dessie Keegan. Jonathan Griffin, who also went by John, with an address at Bray Road, Foxrock , died in October 2023, leaving a €3.6 million estate. He was remembered for his attendance at the United Arts Club and time spent living in Chicago. After his death in November 2024, Cornelius Michael O'Riordan, of Meanus, Kilmallock, Co Limerick, left an estate of just more than €3 million. Monica Sheridan Dauer, of Mount Dutton House, Oldcastle, Co Meath, left an estate valued at €2.9 million when she died in August 2024. Eilis (Alice) Tansey, of Avoca Avenue, Blackrock , Co Dublin, who died on March 8th, 2024, left €2.9 million. Edward (Ned) Grace of Seapoint Avenue, Blackrock, Co Dublin, a retired Smurfit executive, left an estate worth €2.4 million when he died in December 2024. Lucy Mary Teresa Gannon and Kathleen Gannon, of a shared address on Serpentine Park, Ballsbridge, Dublin, each left €1.4 million upon their deaths in December 2020 and November 2022 respectively. Seán Gallagher, of Stillorgan Grove, Blackrock previously of CTT and Enterprise Ireland , left an estate of €1.2 million upon his death in January 2023. The estate figures represent the total value of all assets at the time of a person's death. They typically include the value of a family home or farm and investments.
Irish Times
13 hours ago
- Irish Times
My raspberry plants are producing very few berries – are they a lost cause?
My raspberry plants have produced very few berries this year and some of the stems have died back completely. Should I write them off as a lost cause? Home-grown raspberries bursting with flavour and freshly harvested from the garden are an utter joy. But while the plants, or canes as they're properly known, are very hardy and usually relatively easy to grow so long as they're given fertile, weed-free, humus-rich, free-draining soil and protection from birds, they are unfortunately also prone to a number of viruses that can weaken and eventually kill them. These can be transmitted mechanically by gardening tools, as well as by aphids or some soil-dwelling nematodes, causing symptoms such as stunted growth, mottling and yellowing of leaves, puckering of leaves, 'crumbly' fruit, and poor fruiting. Let's start, however, with the growing conditions. Are they as described above? If not, then this could be the problem. Raspberries hate poorly drained soil, for example, which will almost certainly cause dieback. So can a very alkaline soil. If either is the case, then consider building a raised bed and filling it with fertile top soil enriched with well-rotted manure or home-made garden compost. READ MORE Annual mulches around the base of the plants in spring will help to maintain soil fertility and suppress weed growth, while a few handfuls of a slow-release pelleted organic fertiliser will also help with healthy growth and fruiting. Bear in mind that raspberry plants also need regular pruning to fruit well, with both the particular technique and timing dependent on whether they're summer-fruiting or autumn-fruiting varieties (see ). However, if your plants have indeed become virused, then you'll need to carefully dig them up and destroy them, including all parts of the root system, before planting again with new plants in the autumn. Make sure you source their replacements from a reputable garden centre or nursery as certified virus free. It's also important to plant these in a different area of your garden to minimise the risk of reinfection.
Irish Times
2 days ago
- Irish Times
‘People are really struggling': Cost pressures forcing asthma patients to cut back on medication, says Asthma Society
Nearly a quarter of respondents to a survey by the Asthma Society of Ireland have said they went without asthma medication in the previous three months because of its cost. Combination inhalers, the 'gold standard' for asthma control, cost between €65 and €85 each and are going up in price, ASI chief executive Eilís Ní Chaithnín told The Irish Times. 'It may seem manageable, but it's not for a quarter of the people who responded to our survey', said Ms Ní Chaithnín. 'People are really struggling.' This is especially acute at pinch points, such as the beginning of the new school term when people have extra household costs, she said. The ASI said the price of medication combined with cost-of-living pressures have caused an 'affordability crisis' for the estimated 450,000 people living with asthma in Ireland. READ MORE Of the 627 patients or their parents who respondent to ASI's survey, 56 per cent said they had experienced difficulties making ends meet. The cost burden on people with severe asthma, which requires much greater amounts of medication to control it, is even higher. 'That's €80 a month for the rest of my life, it's a financial commitment,' said Emily Smyth, who was diagnosed with severe asthma in her 20s and is a recipient of the drug payment scheme. '[Medication is] not something you can forgo safely. But people are backed into a corner and have to choose between paying their mortgage, their bills or their medication,' Ms Smyth said. [ Hay fever and asthma sufferers face more severe symptoms due to agricultural fertilisers - study Opens in new window ] ASI's submission describes 'systemic gaps' in asthma diagnosis and treatment which create a long-term financial burden from poorer health outcomes. The organisation is calling on the Government to allocate €14 million to subsidise asthma medications in 2026. Prof Marcus Butler, medical director at ASI, said subsidisation of inhalers was important because '[they] are proven to be extremely effective in controlling asthma and reducing symptoms which, of course, has a positive knock-on effect for the patient and the healthcare system.' 'The most recent CSO figures available to us show that 87 people died from asthma in 2022, with provisional figures indicating this trend has continued into 2023 and 2024. The majority of these deaths are preventable', he said. The society also suggests that the threshold for the drugs payment scheme be reduced by €8 to €72 and that prescription charges for medical card holders be abolished, at an estimated cost of €84.5 million to the exchequer. They want further attention to be paid to severe asthma patients and free home energy upgrades for people with chronic respiratory conditions at risk of energy poverty. 'By these relatively inexpensive measures the Government can enhance the lives of those hundreds of thousands [of asthma patients]. We've been calling on the Government for years to subsidise medication and today we're offering a very pragmatic approach," Ms Ní Chaithnín said. 'Financial barriers should never be a reason that we don't seek healthcare', Ms Smyth said. 'We should all have access to care, we should all have access to medication.'
